Patents Examined by Mark Navaro
  • Exposed proliferation-related peptides, ligands and methods employing the same
    Patent number: 8501419
    Abstract: Novel thymidine kinase (TK1) derived peptide consisting of the amino acid sequence of SEQ ID NO:1 or SEQ ID NO:2 is employed to obtain ligands having specificity to the peptide. The ligand may be an antibody or fragment thereof and may be used in various methods and kits for health screening and the like.
    Type: Grant
    Filed: May 23, 2008
    Date of Patent: August 6, 2013
    Assignee: Arocell AB
    Inventor: Staffan Eriksson